Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 6—June 2021
Research

Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 20201

Kirsten E. Wiens, Pinyi Nyimol Mawien, John Rumunu, Damien Slater, Forrest K. Jones, Serina Moheed, Andrea Caflisch, Bior K. Bior, Iboyi Amanya Jacob, Richard Lino Lako, Argata Guracha Guyo, Olushayo Oluseun Olu, Sylvester Maleghemi, Andrew Baguma, Juma John Hassen, Sheila K. Baya, Lul Deng, Justin Lessler, Maya N. Demby, Vanessa Sanchez, Rachel Mills, Clare Fraser, Richelle C. Charles2, Jason B. Harris2, Andrew S. Azman3Comments to Author , and Joseph F. Wamala3
Author affiliations: Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA (K.E. Wiens, F.K. Jones, J. Lessler, M.N. Demby, A.S. Azman); Republic of South Sudan Ministry of Health, Juba, South Sudan (P.N. Mawien, J. Rumunu, B.K. Bior, I.A. Jacob, R.L. Lako, L. Deng); Massachusetts General Hospital, Boston, Massachusetts, USA (D. Slater, S. Moheed, V. Sanchez, R. Mills, C. Fraser, R.C. Charles, J.B. Harris); International Organization for Migration, Juba (A. Caflisch); World Health Organization, Juba (A.G. Guyo, O.O. Olu, S. Maleghemi, A. Baguma, J.J. Hassen, S.K. Baya, J.F. Wamala); Kabale University School of Medicine, Kabale, Uganda (A. Baguma); Harvard Medical School, Boston (R.C. Charles, J.B. Harris); Médecins Sans Frontières, Geneva, Switzerland (A.S. Azman); Institute of Global Health, Geneva (A.S. Azman)

Main Article

Table 1

Characteristics of participants with interview data available (n = 1,840) from survey of seroprevalence of SARS-CoV-2 IgG in Juba, South Sudan*

Characteristic No. (%)
Sex
F 1,149 (62.4)
M
 691 (37.6)
Age, y
1–4 68 (3.7)
5–9 224 (12.2)
10–19 448 (24.3)
20–29 459 (24.9)
30–39 307 (16.7)
40–49 139 (7.6)
50–64 120 (6.5)
>65
 75 (4.1)
Payam
Northern Bari 788 (42.8)
Juba 141 (7.7)
Muniki 397 (21.6)
Kator 229 (12.4)
Rejaf 135 (7.3)
Gondokoro
 150 (8.2)
Occupation
None 408 (22.2)
Child 386 (21.0)
Student 388 (21.1)
Market merchant 89 (4.8)
Healthcare worker 12 (0.7)
Taxi driver 16 (0.9)
Farmer 164 (8.9)
Working with animals 10 (0.5)
Civil servant 120 (6.5)
Health laboratory worker 2 (0.1)
Teacher 20 (1.1)
Traditional healer 1 (0.1)
Religious leader 8 (0.4)
Other
 216 (11.7)
Reported test for SARS-CoV-2
No 1816 (98.7)
Yes 22 (1.2)
Unknown
 2 (0.1)
Reported SARS-CoV-2 test results
Negative 15 (0.8)
Positive 5 (0.3)
Unknown 2 (0.1)

*SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

Main Article

1A portion of this research was presented at the United States–Japan Cooperative Medical Sciences Program—Virtual Workshop on COVID-19, February 24–26, 2021.

2These authors contributed equally to this article.

3These authors contributed equally to this article.

Page created: March 25, 2021
Page updated: May 18, 2021
Page reviewed: May 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external